- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06432686
Neurophysiological Effects of Transcutaneous Electrical Nerve Stimulation in Persons With MS
September 3, 2025 updated by: University Medical Center Groningen
Neurophysiological Effects of Transcutaneous Electrical Nerve Stimulation in Persons With MS - a Pilot Study
Transcutaneous Electrical Nerve Stimulation (TENS) is a treatment that could potentially reduce walking problems and fatigue in persons with Multiple Sclerosis.
However, extensive use of TENS in a clinical setting is hindered by a lack of neurophysiological understanding of the effects of TENS.
The primary objective of this pilot study is therefore to investigate the effects of TENS on brain activity in pwMS measured with fMRI.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
This study is an exploratory study to see if we can detect changes in fMRI activity during TENS in persons with MS.
This is a randomized, single-blind crossover design.
Subjects will undergo an MRI scan while they receive sham stimulation of the tibialis anterior, active stimulation of the tibialis anterior, stimulation of the quadriceps, perform continuous movements of the foot (plantar & dorsiflexion) and a combination of stimulation of the tibialis anterior and movement of the foot.
This study will include 15 subjects with relapsing remitting or progressive MS and 15 healthy controls.
Blood-oxygen-level-dependent (BOLD) activation changes and the interaction networks before, during and after active TENS and differences in activation due to stimulation on quadriceps vs. tibialis anterior, stimulation on tibialis anterior vs plantar/dorsiflexion and stimulation on tibialis anterior vs stimulation combined with plantar/dorsiflexion.
This will be compared between pwMS and healthy controls.
This study can add to the limited knowledge and possibly help to personalize and implement TENS in the clinic.
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nikki Dreijer
- Phone Number: 0625647172
- Email: n.dreijer@umcg.nl
Study Contact Backup
- Name: Inge Zijdewind
- Email: c.a.t.zijdewind@umcg.nl
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- age: 18-65 years
- EDSS score < 7
Exclusion Criteria:
- metal or electrical implants
- BMI > 40
- claustrophobia
- being pregnant
- having a psychiatric disorder
- having cognitive or communication problems which reduces the capacity to understand instructions
- having a neurological disorder other than MS
- having cardiac arrhythmia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: sham stimulation of the tibialis anterior
|
Transcutaneous electrical nerve stimulation (TENS) is a safe, relatively cheap, and non-painful stimulation of the peripheral sensory and motor nerves.
The stimulator is easy to operate and pwMS can apply the stimulation themselves at home.
This makes TENS an interesting tool to augment sensory input.
A high frequency and long pulse duration is used.
|
|
Experimental: active stimulation of the tibialis anterior
|
Transcutaneous electrical nerve stimulation (TENS) is a safe, relatively cheap, and non-painful stimulation of the peripheral sensory and motor nerves.
The stimulator is easy to operate and pwMS can apply the stimulation themselves at home.
This makes TENS an interesting tool to augment sensory input.
A high frequency and long pulse duration is used.
|
|
Experimental: active stimulation of the quadriceps
|
Transcutaneous electrical nerve stimulation (TENS) is a safe, relatively cheap, and non-painful stimulation of the peripheral sensory and motor nerves.
The stimulator is easy to operate and pwMS can apply the stimulation themselves at home.
This makes TENS an interesting tool to augment sensory input.
A high frequency and long pulse duration is used.
|
|
Active Comparator: continuous movement of the foot (plantar & dorsiflexion)
|
Participants are instructed to perform plantar- and dorsi-flexion contraction in a relatively slow tempo.
The movement of the ankle is measured by an MRI-compatible potentiometer and participants receive feedback of this movement on the screen inside the scanner.
|
|
Sham Comparator: a combination of sham stimulation of the tibialis anterior and movement of the foot
|
Transcutaneous electrical nerve stimulation (TENS) is a safe, relatively cheap, and non-painful stimulation of the peripheral sensory and motor nerves.
The stimulator is easy to operate and pwMS can apply the stimulation themselves at home.
This makes TENS an interesting tool to augment sensory input.
A high frequency and long pulse duration is used.
Participants are instructed to perform plantar- and dorsi-flexion contraction in a relatively slow tempo.
The movement of the ankle is measured by an MRI-compatible potentiometer and participants receive feedback of this movement on the screen inside the scanner.
|
|
Experimental: a combination of active stimulation of the tibialis anterior and movement of the foot
|
Transcutaneous electrical nerve stimulation (TENS) is a safe, relatively cheap, and non-painful stimulation of the peripheral sensory and motor nerves.
The stimulator is easy to operate and pwMS can apply the stimulation themselves at home.
This makes TENS an interesting tool to augment sensory input.
A high frequency and long pulse duration is used.
Participants are instructed to perform plantar- and dorsi-flexion contraction in a relatively slow tempo.
The movement of the ankle is measured by an MRI-compatible potentiometer and participants receive feedback of this movement on the screen inside the scanner.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BOLD activation due to TENS
Time Frame: 1 hour fMRI scan
|
Blood level detection activation (BOLD) changes and interaction networks before, during and after active TENS and differences in activation due to stimulation on quadriceps vs. tibialis anterior, stimulation on tibialis anterior vs plantar/dorsiflexion and stimulation on tibialis anterior vs stimulation combined with plantar/dorsiflexion.
We focus on the thalamus (integration station of sensory input), sensory cortex (sensory awareness) and motor cortices (sensorimotor integration).
|
1 hour fMRI scan
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
October 1, 2025
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
May 22, 2024
First Submitted That Met QC Criteria
May 22, 2024
First Posted (Actual)
May 29, 2024
Study Record Updates
Last Update Posted (Estimated)
September 10, 2025
Last Update Submitted That Met QC Criteria
September 3, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Nervous System Diseases
- Autoimmune Diseases
- Immune System Diseases
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Multiple Sclerosis
- Fatigue
- Mobility Limitation
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Therapeutics
- Physical Therapy Modalities
- Physiological Phenomena
- Rehabilitation
- Anesthesia and Analgesia
- Electric Stimulation Therapy
- Analgesia
- Movement
- Transcutaneous Electric Nerve Stimulation
Other Study ID Numbers
- MS-fMRI-TENS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Transcutaneous Electrical Nerve Stimulation
-
University of L'AquilaCompleted
-
Karolinska University HospitalActive, not recruitingHip Fractures | Orthopedic Disorder | Post Operative Pain | Arthroplasty, Replacement, Hip | Internal FixationSweden
-
University of Colorado, BoulderUniversity of Colorado, Denver; Colorado State UniversityWithdrawn
-
ADIR AssociationCompletedChronic Obstructive Pulmonary DiseaseFrance
-
University of MichiganThe Craig H. Neilsen Foundation; International Society for the Study of Women...CompletedSpinal Cord Injuries | Female Sexual DysfunctionUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedTendinopathy | Cervical Radiculopathy | Post-herpetic Neuralgia | Chronic Back Pain | Limbs Arthrosis | Non Arthrosic Limbs Arthralgia | Chronic Lomboradiculalgia | Post-surgical Peripheral Neuropathic Pain | Post Trauma Neuropathic Pain | Complex Regional Pain Syndrome Type I or IIFrance
-
University Hospital, ToulouseMinistry of Health, FranceTerminatedPeripheral Artery DiseaseFrance
-
Université de SherbrookeCompleted
-
Institut Cancerologie de l'OuestTerminated
-
Secretaria Municipal de Saúde de RolanteCentro Universitario La SalleUnknown